Tuesday, 02 January 2024 12:17 GMT

Embecta To Participate In Investor Events


(MENAFN- GlobeNewsWire - Nasdaq) PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2026 Jefferies Global Healthcare Conference

  • Management will host one-on-one investor meetings on Wednesday, June 3, 2026, at the Marriott Marquis, New York City.

TD Cowen Diabetes Tech Summit

  • Management will host a fireside session on Friday, June 5, 2026, at 9:40 a.m. CT / 10:40 a.m. ET, at the Westin New Orleans, LA.

2026 Goldman Sachs 47th Annual Global Healthcare Conference

  • Management will host one-on-one investor meetings on Tuesday, June 9, 2026, at the Loews Miami Beach Hotel, Miami, FL.

2026 Truist Securities MedTech Conference

  • Management will host one-on-one investor meetings on Tuesday, June 16, 2026, at the Boston Harbor Hotel, MA.

About embecta

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

Media Investors
Christian Glazar Pravesh Khandelwal
Sr. Director, Corporate Communications VP, Head of Investor Relations
908-821-6922 551-264-6547
Contact Media Relations Contact IR



MENAFN01062026004107003653ID1111195855



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search